In vitro and in vivo studies of fept nanoparticles for dual modal CT/MRI molecular imaging

Shang Wei Chou, Yu Hong Shau, Ping Ching Wu, Yu Sang Yang, Dar Bin Shieh, Chia Chun Chen

研究成果: 雜誌貢獻文章

247 引文 (Scopus)

摘要

The water-solvable FePt nanoparticles of 3, 6, and 12 nm in diameter (3 nm-, 6 nm-, and 12 nm-FePt) were synthesized and applied as a dual modality contrast agent for CT/MRI molecular imaging. These nanoparticles present excellent biocompatibility and hemocompatibility in all test concentrations for the imaging contrast. The biodistribution analysis revealed the highest serum concentration and circulation half-life for 12 nm-FePt, followed by 6 nm-FePt then 3 nm-FePt. Thus, the 3 nm-FePt showed higher brain concentrations. Anti-Her2 antibody conjugated FePt nanoparticles demonstrated molecular expression dependent CT/MRI dual imaging contrast effect in MBT2 cell line and its Her2/neu gene knock out counterpart. Selective contrast enhancement of Her2/neu overexpression cancer lesions in both CT and MRI was found in tumor bearing animal after tail vein injection of the nanoparticles. The 12 nm-FePt outperformed 3 nm-FePt in both imaging modalities. These results indicate the potential of FePt nanoparticles to serve as novel multimodal molecular imaging contrast agents in clinical settings.

原文英語
頁(從 - 到)13270-13278
頁數9
期刊Journal of the American Chemical Society
132
發行號38
DOIs
出版狀態已發佈 - 2010 九月 29

指紋

Molecular imaging
Molecular Imaging
Nanoparticles
Magnetic resonance imaging
Imaging techniques
Contrast Media
Bearings (structural)
Multimodal Imaging
erbB-2 Genes
Gene Knockout Techniques
Biocompatibility
Antibodies
Half-Life
Tumors
Anti-Idiotypic Antibodies
Veins
Brain
Neoplasms
Animals
Genes

ASJC Scopus subject areas

  • Catalysis
  • Chemistry(all)
  • Biochemistry
  • Colloid and Surface Chemistry

引用此文

In vitro and in vivo studies of fept nanoparticles for dual modal CT/MRI molecular imaging. / Chou, Shang Wei; Shau, Yu Hong; Wu, Ping Ching; Yang, Yu Sang; Shieh, Dar Bin; Chen, Chia Chun.

於: Journal of the American Chemical Society, 卷 132, 編號 38, 29.09.2010, p. 13270-13278.

研究成果: 雜誌貢獻文章

Chou, Shang Wei ; Shau, Yu Hong ; Wu, Ping Ching ; Yang, Yu Sang ; Shieh, Dar Bin ; Chen, Chia Chun. / In vitro and in vivo studies of fept nanoparticles for dual modal CT/MRI molecular imaging. 於: Journal of the American Chemical Society. 2010 ; 卷 132, 編號 38. 頁 13270-13278.
@article{beb1a81c113c46038cc14c9c88595f38,
title = "In vitro and in vivo studies of fept nanoparticles for dual modal CT/MRI molecular imaging",
abstract = "The water-solvable FePt nanoparticles of 3, 6, and 12 nm in diameter (3 nm-, 6 nm-, and 12 nm-FePt) were synthesized and applied as a dual modality contrast agent for CT/MRI molecular imaging. These nanoparticles present excellent biocompatibility and hemocompatibility in all test concentrations for the imaging contrast. The biodistribution analysis revealed the highest serum concentration and circulation half-life for 12 nm-FePt, followed by 6 nm-FePt then 3 nm-FePt. Thus, the 3 nm-FePt showed higher brain concentrations. Anti-Her2 antibody conjugated FePt nanoparticles demonstrated molecular expression dependent CT/MRI dual imaging contrast effect in MBT2 cell line and its Her2/neu gene knock out counterpart. Selective contrast enhancement of Her2/neu overexpression cancer lesions in both CT and MRI was found in tumor bearing animal after tail vein injection of the nanoparticles. The 12 nm-FePt outperformed 3 nm-FePt in both imaging modalities. These results indicate the potential of FePt nanoparticles to serve as novel multimodal molecular imaging contrast agents in clinical settings.",
author = "Chou, {Shang Wei} and Shau, {Yu Hong} and Wu, {Ping Ching} and Yang, {Yu Sang} and Shieh, {Dar Bin} and Chen, {Chia Chun}",
year = "2010",
month = "9",
day = "29",
doi = "10.1021/ja1035013",
language = "English",
volume = "132",
pages = "13270--13278",
journal = "Journal of the American Chemical Society",
issn = "0002-7863",
publisher = "American Chemical Society",
number = "38",

}

TY - JOUR

T1 - In vitro and in vivo studies of fept nanoparticles for dual modal CT/MRI molecular imaging

AU - Chou, Shang Wei

AU - Shau, Yu Hong

AU - Wu, Ping Ching

AU - Yang, Yu Sang

AU - Shieh, Dar Bin

AU - Chen, Chia Chun

PY - 2010/9/29

Y1 - 2010/9/29

N2 - The water-solvable FePt nanoparticles of 3, 6, and 12 nm in diameter (3 nm-, 6 nm-, and 12 nm-FePt) were synthesized and applied as a dual modality contrast agent for CT/MRI molecular imaging. These nanoparticles present excellent biocompatibility and hemocompatibility in all test concentrations for the imaging contrast. The biodistribution analysis revealed the highest serum concentration and circulation half-life for 12 nm-FePt, followed by 6 nm-FePt then 3 nm-FePt. Thus, the 3 nm-FePt showed higher brain concentrations. Anti-Her2 antibody conjugated FePt nanoparticles demonstrated molecular expression dependent CT/MRI dual imaging contrast effect in MBT2 cell line and its Her2/neu gene knock out counterpart. Selective contrast enhancement of Her2/neu overexpression cancer lesions in both CT and MRI was found in tumor bearing animal after tail vein injection of the nanoparticles. The 12 nm-FePt outperformed 3 nm-FePt in both imaging modalities. These results indicate the potential of FePt nanoparticles to serve as novel multimodal molecular imaging contrast agents in clinical settings.

AB - The water-solvable FePt nanoparticles of 3, 6, and 12 nm in diameter (3 nm-, 6 nm-, and 12 nm-FePt) were synthesized and applied as a dual modality contrast agent for CT/MRI molecular imaging. These nanoparticles present excellent biocompatibility and hemocompatibility in all test concentrations for the imaging contrast. The biodistribution analysis revealed the highest serum concentration and circulation half-life for 12 nm-FePt, followed by 6 nm-FePt then 3 nm-FePt. Thus, the 3 nm-FePt showed higher brain concentrations. Anti-Her2 antibody conjugated FePt nanoparticles demonstrated molecular expression dependent CT/MRI dual imaging contrast effect in MBT2 cell line and its Her2/neu gene knock out counterpart. Selective contrast enhancement of Her2/neu overexpression cancer lesions in both CT and MRI was found in tumor bearing animal after tail vein injection of the nanoparticles. The 12 nm-FePt outperformed 3 nm-FePt in both imaging modalities. These results indicate the potential of FePt nanoparticles to serve as novel multimodal molecular imaging contrast agents in clinical settings.

UR - http://www.scopus.com/inward/record.url?scp=77957108931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957108931&partnerID=8YFLogxK

U2 - 10.1021/ja1035013

DO - 10.1021/ja1035013

M3 - Article

C2 - 20572667

AN - SCOPUS:77957108931

VL - 132

SP - 13270

EP - 13278

JO - Journal of the American Chemical Society

JF - Journal of the American Chemical Society

SN - 0002-7863

IS - 38

ER -